Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

3607

LikeLikedUnlike

451-465 of 959

FSGS in Practice: Patient-Centered Decision-Making
CME/CE
FSGS in Practice: Patient-Centered Decision-Making
- Kenneth Lieberman, MD
  Peer
- Howard Trachtman, MD, FASN
  Peer
0.25 credits
MinuteCE®
APOC3 Inhibition: New Frontiers Managing Patients with FCS & SHTG
- Daniel Gaudet, MD, PhD
  Peer
- Børge G. Nordestgaard, MD, DMSc
  Peer
- Pam R. Taub, MD, FACC, FASPC
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 credits 9 episodes
Shifting Treatment Paradigm in HFmrEF/HFpEF: Steroidal and Nonsteroidal MRAs
CME/CE
Shifting Treatment Paradigm in HFmrEF/HFpEF: Steroidal and Nonsteroidal MRAs
- Faiez Zannad, MD, PhD
  Peer
- John McMurray, MD
  Peer
0.25 credits
FCS: Enhancing the Diagnosis
MinuteCE®
FCS: Enhancing the Diagnosis
- Daniel Gaudet, MD, PhD
  Peer
1.00 program credits
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
MinuteCE®
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
- Børge G. Nordestgaard, MD, DMSc
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits
APOC3 Inhibition: A Novel Approach to Lowering TGs
MinuteCE®
APOC3 Inhibition: A Novel Approach to Lowering TGs
- Børge G. Nordestgaard, MD, DMSc
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits
advertisement
Latest Clinical Trial Outcomes and Breakthroughs for FCS
MinuteCE®
Latest Clinical Trial Outcomes and Breakthroughs for FCS
- Daniel Gaudet, MD, PhD
  Peer
- Pam R. Taub, MD, FACC, FASPC
  Peer
1.00 program credits
SHTG: Defining the Unmet Clinical Need
MinuteCE®
SHTG: Defining the Unmet Clinical Need
- Pam R. Taub, MD, FACC, FASPC
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits
SHTG: Decoding the Latest Clinical Trial Outcomes
MinuteCE®
SHTG: Decoding the Latest Clinical Trial Outcomes
- Pam R. Taub, MD, FACC, FASPC
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits
Remnant Cholesterol: The Missing Link in ASCVD risk
MinuteCE®
Remnant Cholesterol: The Missing Link in ASCVD risk
- Børge G. Nordestgaard, MD, DMSc
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits
Targeting Mixed Hyperlipidemia with APOC3 Inhibition
MinuteCE®
Targeting Mixed Hyperlipidemia with APOC3 Inhibition
- Pam R. Taub, MD, FACC, FASPC
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits
The Road Ahead: What's on the Horizon for FCS and SHTG Management
MinuteCE®
The Road Ahead: What's on the Horizon for FCS and SHTG Management
- Pam R. Taub, MD, FACC, FASPC
  Peer
- Prof. Kausik Ray
  Peer
1.00 program credits
advertisement
Equity in Sight: Addressing Disparities with Advanced Treatment Approaches
CME/CE
Equity in Sight: Addressing Disparities with Advanced Treatment Approaches
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
- Jeremiah Brown Jr., MD, MS, FASRS
  Peer
- Rahul N. Khurana, MD, FASRS
  Peer
1.00 credits
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
CME/CE
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
- C. Michael Gibson, MD, MS
  Peer
- Roxana Mehran, MD, FSCAI
  Peer
1.00 credits
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
CME/CE
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
- Neal Shore, MD, FACS
  Peer
- Sarah Psutka, MD, MS
  Peer
0.25 credits

Program Chapters

Segment Chapters

Playlist:

Recommended